Review
Takashi Kiyoizumi, MD, PhD, SM

- M.D. and Ph.D. from Keio University School of Medicine
- MBA from Sloan School of Management at MIT
Sadashi Suzuki, MBA

Mr. Suzuki started his 40+ yrs career in healthcare/life sciences with Kyowa Hakko. Recently, he held a series of management positions at Japan divisions of global companies, Baxter Japan, Alcon Japan, and Affymetrix Japan (CEO), Bio-Rad Laboratories Japan (CEO),Cepheid Japan,(CEO). Currently, he is the head of the Japan office of Newton Biocapital (Belgium base VC). He has extensive experience working with Japanese regulatory authorities on securing the approval of medical devices, testing equipment, reagents and compounds.
- MBA from Kellogg School at Northwestern Univ.
Takuma Aoyama, MBA, MHCDS

Mr. Aoyama is the founder of AIFAM Group, a global asset manager focused on alternative assets. Mr. Aoyama has spearheaded investments across the liquidity spectrum from hedge funds to private equity and venture capital. Prior to founding AIFAM, Mr. Aoyama was at UBS Global Asset Management in Chicago (then, Head Quarters) and Long-Term Credit Bank of Japan (US/Japan).
- MBA from University of Chicago, MS from Dartmouth College
Hajime Oshita

Yoshiharu Mizui, PhD

Fumitaka Mori, PhD

Ryutaro Adachi, PhD

Justin Klein, MD, JD

Marc Martin-Casas, PhD

Takashi Futami, PhD, MBA

- MS in Chemistry and Biotechnology from The University of Tokyo
- Ph.D. in Life Science Innovation from University of Tsukuba
Awareness Building / Education
Tomoyoshi Koyanagi, PhD

TBAP Support Member. Professor, Faculty of Medicine. Head of Translational Research Promotion &Education Center, Tsukuba Clinical Research & Development Organization, University of Tsukuba.
Dr. Koyanagi is a business development professional with hands-
on experience in supporting startups in the medical field. At the University of Tsukuba, he co-founded Research Studio powered by SPARK, a platform for fostering medical entrepreneurs. Prior to his academic career as an entrepreneurship trainer, he worked as a marketing and project management specialist in multinational corporations and start-ups. He received post-doctoral training at Stanford University and a Ph.D. from Osaka University.
Administration
Taro Masunaga, PhD

Mr. Masunaga was Executive Vice President and Head of Discovery Accelerator at Astellas Pharma Inc prior to joining Triple Bridge. While at Astellas, he had multiple global roles as research leadership, venture capitalist, early-stage business development and strategy & portfolio.
- Ph.D. from Hokkaido University, BS from Kyushu University
Shinobu Mori, PhD

Ms. Mori was Vice President and Head of Science Intelligence & Solutions, Discovery Accelerator at Astellas. While leading its initiative of venture unit at Astellas, she was dedicated and involved in development of drug discovery ecosystem in Japan.
- Ph.D. in Pharmaceutical Sciences from Tohoku University
Yuki Misaki
